In this respect, Arbizu et al. [25] reported an increased expression of TLR-4 mRNA of about 2.5-fold with respect to control in HT-29 colon cancer cells treated with LPS at 4 μg mL−1 concentration [25]. The gene discussed is TLR4; the disease is colonic neoplasm.